Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

Philip Bischoff; Martin Reck; Tobias R. Overbeck; Petros Christopoulos; Achim Rittmeyer; H Lüders; Jens Kollmeier; Jonas Kulhavy; Marcel Kemper; Niels Reinmuth; Julia Röper; Melanie Janning; Linna Sommer; Lukas Aguinarte; Myriam Koch; Marcel Wiesweg; Claas Wesseler; Cornelius F. Waller; Diego Kauffmann‐Guerrero; Albrecht Stenzinger; Susann Stephan-Falkenau; Marcel Trautmann; Silke Laßmann; Markus Tiemann; Frederick Klauschen; Martin Sebastian; Frank Griesinger; Jürgen Wolf; Sonja Loges; Nikolaj Frost; Moritz Hilbrandt; Juliane Süptitz; Christian Grah; Janna-Lisa Velthaus; Hans‐Georg Kopp; Bernd Schmidt; Susanne Horter; Stefanie Keymel; Enver Aydilek; Guergana Tritchkova; Matthias Raspe; Dražen Papić; Stefan Florian; David Horst; Peter J. Wild; Michael Thomas; Christian Grohé; Annalen Bleckmann; Martin Wermke; Horst-Dieter Hummel; Jan Stratmann; Wolfgang Schütte

doi:10.1016/j.jtho.2023.12.015

Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

Philip Bischoff(German Cancer Research Center), Martin Reck(LungenClinic Grosshansdorf), Tobias R. Overbeck(Universitätsmedizin Göttingen), Petros Christopoulos(Heidelberg University), Achim Rittmeyer, H Lüders(Evangelische Lungenklinik Berlin), Jens Kollmeier(Helios Klinikum Emil von Behring), Jonas Kulhavy(Comprehensive Cancer Center Mainfranken), Marcel Kemper(University Hospital Münster), Niels Reinmuth(German Center for Lung Research), Julia Röper(Pius Hospital Oldenburg), Melanie Janning(German Cancer Research Center), Linna Sommer(University Hospital Carl Gustav Carus), Lukas Aguinarte(Goethe University Frankfurt), Myriam Koch(University Hospital Regensburg), Marcel Wiesweg(Essen University Hospital), Claas Wesseler(Asklepios Klinikum Harburg), Cornelius F. Waller(University Medical Center Freiburg), Diego Kauffmann‐Guerrero(Merck (Germany)), Albrecht Stenzinger(Heidelberg University), Susann Stephan-Falkenau(Helios Klinikum Emil von Behring), Marcel Trautmann(University of Münster), Silke Laßmann(University of Freiburg), Markus Tiemann(Merck (Germany)), Frederick Klauschen(Merck (Germany)), Martin Sebastian(Goethe University Frankfurt), Frank Griesinger(Pius Hospital Oldenburg), Jürgen Wolf(Merck (Germany)), Sonja Loges(Essen University Hospital), Nikolaj Frost(Merck (Germany)), Moritz Hilbrandt, Juliane Süptitz, Christian Grah, Janna-Lisa Velthaus, Hans‐Georg Kopp, Bernd Schmidt, Susanne Horter, Stefanie Keymel, Enver Aydilek, Guergana Tritchkova, Matthias Raspe, Dražen Papić, Stefan Florian, David Horst, Peter J. Wild, Michael Thomas, Christian Grohé, Annalen Bleckmann, Martin Wermke(Goethe University Frankfurt), Horst-Dieter Hummel, Jan Stratmann(German Cancer Research Center), Wolfgang Schütte

Journal of Thoracic Oncology

December 13, 2023

10.1016/j.jtho.2023.12.015

Cited by 47Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis